Kun for helsepersonell

Viktig sikkerhets-og forskrivningsinformasjon: Breyanzi® (lisocabtagene maraleucel)

image

Post-CAR-T treatment and outpatient setting

Interview: 2 minutes

Listen in to insights on potential management of outpatient care and follow-up of CAR-T treatment in R/R LBCL by Mats Hellström, MD PhD, oncologist, adjunct associate professor at Uppsala University.

Related videos

Biomarkers in LBCL
Optimizing CAR-T Bridging Therapy in LBCL

News

Learn about current topics in hematology, such as new research data, news from events, congresses and more.

Education

Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.

 

HE-NOR-2500030 video/ 2009-NO-2500020 Dec 2025